
Aerbio
Biotech company producing sustainable single-cell protein from CO2 and hydrogen.
About
Aerbio is a biotechnology company that has developed the (R)evolve™ platform, which uses carbon dioxide and hydrogen as feedstock to produce high-quality, single-cell protein. Their flagship product, Proton™, is a sustainable alternative to traditional protein sources for food and animal nutrition.
Key facts
At-a-glance profile data
- Website
- aer.bio
- Founded
- 2018
- Total funding
- $87M (Bridge Loan)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Oct 2024 | Bridge Loan | $34M | - |
| 17 Jul 2020 | Grant | $4M | - |
Tech stack
Detected on aer.bio, last scanned 23 Sept 2026. Run your own scan
- Frontend
- Next.js, Tailwind CSS
- CDN
- Vercel
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
- Video / media
- Vimeo
Add first review
Frequently asked
How much funding has Aerbio raised?
Aerbio has raised a total of $87M in funding. The most recent round on record is Bridge Loan.
